Clinical trial
The Correlative Cohort Study on the Clinical Features and Prognosis of Drug-induced Liver Injury
NCT04302506 is registered in ClinicalTrials.gov with Beijing Ditan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Correlative Cohort Study on the Clinical Features and Prognosis of Drug-induced Liver Injury
- Lead sponsor
- Beijing Ditan Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 1, 2020
- Completion date
- April 30, 2021
- Enrollment
- 600 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
drug-induced liver injury